Intraductal salivary gland irrigation
a critical appraisal of an alternative treatment approach for patients with hyposalivation and xerostomia
DOI:
https://doi.org/10.61872/sdj-2026-02-01PMID:
42246168Keywords:
salivary gland irrigation, hyposalivation, xerostomia, dry mouth, saliva, salivary flow, salivary glandsAbstract
Xerostomia and hyposalivation impair oral function and quality of life. Current therapies are largely palliative, and systemic sialogogues are often limited by side effects or contraindications. Intraductal salivary gland irrigation (IDSGI) has emerged as an alternative, being a minimally invasive outpatient technique aimed at relieving oral dryness by flushing and stimulation of the major salivary glands with saline or corticosteroid solutions. This technique has been described for various disorders of the salivary glands (e.g. Sjögren’s syndrome, sialadenitis), and substantial objective and subjective benefits following intraductal irrigation have been reported. The present article describes and critically appraises this technique by presenting three randomly chosen patient cases with documented hyposalivation and severe xerostomia. The patients were all treated by intraductal irrigation of their major salivary glands using sterile saline. Before and after therapy, unstimulated and stimulated whole-saliva flow rates, salivary pH, and subjective dryness using a visual analogue scale (VAS) were measured. The procedure was well tolerated with no complications by all three patients included. After one month, unstimulated and stimulated salivary flow rates increased in two cases and one patient previously treated with sialogogues showed no improvement in salivary flow rates. However, all three patients showed a decreased VAS for dryness by 30-50% with subjective improvement persisting also on later check-ups. The cases presented suggest that IDSGI represents a simple and safe outpatient procedure that can improve salivary flow and xerostomia as an adjunct to other conservative measures, particularly when systemically acting sialogogues are ineffective or contraindicated.
References
1. Guggenheimer J, Moore PA. Xerostomia: Etiology, recognition and treatment. J Am Dent Assoc. 2003;134:61–69.
2. Sreebny LM, Valdini A. Xerostomia. Part I. Oral Surg Oral Med Oral Pathol. 1988;66:451–458.
3. Turner MD. Hyposalivation and xerostomia. Dent Clin North Am. 2016;60:435–443.
4. Villa A, Wolff A, Narayana N, et al. World Workshop on Oral Medicine VI: a systematic review of medication-induced salivary gland dysfunction. Oral Dis. 2016;22:365–382.
5. Dawes C. Physiological factors affecting salivary flow rate, oral sugar clearance, and the sensation of dry mouth in man. J Dent Res. 1987;66:648–653.
6. Ship JA, Fox PC, Baum BJ. How much saliva is enough? 'Normal' function defined. J Am Dent Assoc. 1991;122:63–69.
7. Navazesh M, Christensen CM. A comparison of whole mouth resting and stimulated salivary measurement procedures. J Dent Res. 1982;61:1158–1162.
8. Navazesh M. Methods for collecting saliva. Ann N Y Acad Sci. 1993;694:72–77.
9. Furness S, Worthington HV, Bryan G, et al. Interventions for the management of dry mouth: topical therapies. Cochrane Database Syst Rev. 2011. Dec; 12:CD008934.
10. Aframian DJ, Mizrahi B, Granot I, Domb AJ. Evaluation of a mucoadhesive lipid-based bioerodable tablet compared with Biotène mouthwash for dry mouth relief - a pilot study. Quintessence Int. 2010;41:e36–42.
11. Wolff A, Koray M, Campisi G, et al. Electrostimulation of the lingual nerve by an intraoral device may lead to salivary gland regeneration: A case series study. Med Oral Patol Oral Cir Bucal. 2018 Sep 1;23:e552-e559.
12. Talal A, Quinn JH, Daniels TE. The clinical effects of electrostimulation on salivary function of Sjögren's syndrome patients. A placebo-controlled study. J Rheumatol. 1992;19:1031–1035.
13. Fedele S, Al-Hamad S, Mercadante V, et.al. Long‐term effectiveness of a novel intra‐oral electro‐stimulator for the treatment of dry mouth in patients with Sjogren's syndrome: A randomised sham‐controlled feasibility study (LEONIDAS‐1). J Oral Pathol Med. 2023 May;52:619–627.
14. Kapourani A, Kontogiannopoulos KN, Barmpalexis P. A Review on the Role of Pilocarpine on the Management of Xerostomia and the Importance of the Topical Administration Systems Development. Pharmaceuticals (Basel). 2022 Jun 18;15:762.
15. Fife RS, Chase W, Dore R, et al. Cevimeline for the treatment of xerostomia in patients with Sjögren syndrome: a randomized trial. Arch Intern Med. 2002;162:1293–1300.
16. Aframian DJ, Helcer M, Livni D, et al. Pilocarpine treatment in a mixed cohort of xerostomic patients. Oral Dis. 2007;13:88–92.
17. Aframian DJ, Helcer M, Livni D, et al. Pilocarpine for the treatment of salivary glands’ impairment caused by radioiodine therapy. Oral Dis. 2006;12:297–300.
18. Aframian DJ, Baaton S, Mazor S, et al. Improvement of dry mouth following intraductal irrigation of salivary glands. Oral Dis. 2019;25:1735–1743.
19. Lee C, Kim JH, Choi SH, et al. Therapeutic effect of intraductal irrigation of the salivary gland: A technical report. Imaging Sci Dent. 2017;47:123–127.
20. Du H, Fu Z, Zhong Y, et al. A randomized controlled trial to verify the irrigation of salivary glands in relieving xerostomia in patients with Sjögren’s syndrome. Front Immunol. 2022;13:1039599.
21. Kim JE, Lee SS, Lee C, et al. Therapeutic effect of intraductal saline irrigation in chronic obstructive sialadenitis. BMC Oral Health. 2020 Mar;24;20:86.
22. Jensen SB, Pedersen AM, Vissink A, et al. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Support Care Cancer. 2010;18:1039–1060.
23. Shiboski CH, Shiboski SC, Seror R, et. Al. 2016 ACREULAR Classification Criteria for primary Sjögren’s Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts. Arthritis Rheumatol. 2016 Oct;69:35–45.
24. Villa A, Connell CL, Abati S. Diagnosis and management of xerostomia and hyposalivation. Ther Clin Risk Manag. 2014 Dec 22;11:45-51.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Robert Borgos, Fariba Ashrafi, Lisa Velte, Michael M. Bornstein
This work is licensed under a Creative Commons Attribution 4.0 International License.
